Medicare Enrolled

Dr. Dakshesh Patel, MD

Optician · Toms River, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
20 HOSPITAL DR STE 15, Toms River, NJ 08755
7325388100
In practice since 2007 (19 years)
NPI: 1720202278 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patel

Dr. Dakshesh Patel is an optician specialist in Toms River, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 5,185 Medicare services across 2,829 unique beneficiaries.

Between the years covered by Open Payments, Dr. Patel received a total of $4,441 from 56 pharmaceutical and/or device companies across 279 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 12% volume in NJ $4,441 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,185
Medicare services
Top 12% in NJ for optician
2,829
Unique beneficiaries
$119
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~273 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
1,184 $99 $167
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
993 $149 $250
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
978 $66 $126
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
570 $144 $315
Continuous intraoperative neurophysiology monitoring, remote
Remote monitoring of nerve and brain function during surgery, billed in 15-minute increments.
318 $27 $350
New patient office visit, complex (60-74 min) 292 $184 $300
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
146 $85 $205
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
77 $338 $590
Complete ultrasound of brain blood flow
An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation.
74 $189 $425
Ultrasound of brain blood flow following medication
An ultrasound test used to assess blood flow within the brain after a medication has been administered.
73 $196 $450
Ultrasound of brain blood flow
An ultrasound test used to examine blood flow within the brain to check for blood clots.
72 $143 $500
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
55 $213 $500
Assessment of and care planning for patient with impaired thought processing, typically 60 minutes 55 $231 $380
Neuropsychological test evaluation, first hour
A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process.
52 $109 $240
Psychological test administration, first 30 minutes
A technician administers psychological or neuropsychological testing for the first 30 minutes.
52 $30 $70
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
34 $394 $825
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
25 $108 $190
Transitional care management, high complexity
Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem.
25 $236 $396
Ultrasound of brain blood flow
An ultrasound test used to evaluate blood flow within the blood vessels of the brain.
20 $115 $275
Placement of skin electrodes and measurement of stimulated sites on arms and legs
This procedure involves placing skin electrodes and measuring stimulated sites on the arms and legs.
20 $37 $1,120
Electromyography of 2 extremities
A test that measures the electrical activity in the muscles of two arms or legs. It helps evaluate nerve and muscle function.
18 $67 $500
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
18 $182 $410
Transitional care management services, moderate complexity
Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity.
18 $174 $300
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
16 $123 $260
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,441
Total received (2018-2024)
Avg $634/year across 7 years
Top 19% in NJ for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
279
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,102 (92.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$338 (7.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,445
2023
$1,100
2022
$344
2021
$26
2020
$230
2019
$818
2018
$478

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$235
ACADIA Pharmaceuticals Inc
$173
AstraZeneca Pharmaceuticals LP
$153
Otsuka America Pharmaceutical, Inc.
$101
UCB, Inc.
$99
ABBVIE INC.
$95
MDD US Operations, LLC
$88
PFIZER INC.
$74
Eisai Inc.
$68
Teva Pharmaceuticals USA, Inc.
$65
ARGENX US, INC.
$59
Celgene Corporation
$44
SCILEX PHARMACEUTICALS INC.
$41
Neurocrine Biosciences, Inc.
$31
Medtronic, Inc.
$25
Neurelis, Inc.
$17
Alexion Pharmaceuticals, Inc.
$17
Kyowa Kirin, Inc.
$17
Amneal Pharmaceuticals LLC
$15
Sirius Medical Systems
$15
Sumitomo Pharma America, Inc.
$13
Top 3 companies account for 38.8% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$421
ABBVIE INC.
$348
UCB, Inc.
$328
Teva Pharmaceuticals USA, Inc.
$231
ACADIA Pharmaceuticals Inc
$229
Amgen Inc.
$173
Alexion Pharmaceuticals, Inc.
$157
AstraZeneca Pharmaceuticals LP
$153
Novartis Pharmaceuticals Corporation
$152
Otsuka America Pharmaceutical, Inc.
$150
PFIZER INC.
$146
Supernus Pharmaceuticals, Inc.
$145
MDD US Operations, LLC
$133
Eisai Inc.
$123
ARGENX US, INC.
$91
US WorldMeds, LLC
$82
Bayer HealthCare Pharmaceuticals Inc.
$82
EISAI INC.
$73
Celgene Corporation
$72
Corium, LLC
$71
EMD Serono, Inc.
$70
Sumitomo Pharma America, Inc.
$66
Biogen, Inc.
$61
Kyowa Kirin, Inc.
$58
Neurelis, Inc.
$56
Acorda Therapeutics, Inc
$56
Adamas Pharmaceuticals, Inc.
$54
Avanir Pharmaceuticals, Inc.
$52
Genentech USA, Inc.
$44
SCILEX PHARMACEUTICALS INC.
$41
Biohaven Pharmaceutical Holding Company Ltd.
$39
Takeda Pharmaceuticals U.S.A., Inc.
$34
Neurocrine Biosciences, Inc.
$31
Scilex Pharmaceuticals Inc.
$29
Assertio Therapeutics, Inc.
$27
NuVasive, Inc.
$26
Egalet US Inc
$26
Mallinckrodt LLC
$25
Bayer Healthcare Pharmaceuticals Inc.
$25
Medtronic, Inc.
$25
Janssen Pharmaceuticals, Inc
$22
Lundbeck LLC
$16
Amneal Pharmaceuticals LLC
$15
GENZYME CORPORATION
$15
Bausch Health US, LLC
$15
Greenwich Biosciences, Inc.
$15
Sirius Medical Systems
$15
Octapharma USA, Inc.
$15
Akcea Therapeutics, Inc.
$14
Allergan Inc.
$14
AbbVie Inc.
$14
CATALYST PHARMACEUTICALS, INC.
$14
ASSERTIO THERAPEUTICS, Inc.
$14
Zyla Life Sciences
$14
Harmony Biosciences LLC
$13
Biohaven Pharmaceuticals, Inc.
$12
Top 3 companies account for 24.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · AFINITOR · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUSTEDO · AVONEX · Adlarity · Aimovig · Apokyn · Austedo XR · BOTOX THERAPEUTIC · Betaseron · Briviact · CAMBIA · COPAXONE · Cambia · DUOPA · ELYXYB - CELECOXIB · EMGALITY · Epidiolex · FIRDAPSE · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · INBRIJA · INGREZZA · INTELLIS ADAPTIVESTIM · KESIMPTA · KISUNLA · LEMTRADA · Leqembi · MIGRANAL · MYOBLOC · Mavenclad · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · ONGENTYS · OXTELLAR XR · PANZYGA · PINTUITION · Ponvory · QULIPTA · RELINE · REXULTI · Rystiggo · SANCUSO · SOLIRIS · SPRIX · Soliris · TEGSEDI · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · VALTOCO · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · Wakix · XADAGO · Xadago · ZAVZPRET · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an optician specialist in Toms River?
Compare opticians in the Toms River area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
288
Per 100K population
44.6
County median income
$86,411
Nearest hospital
COMMUNITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Patel is a clinical cardiology specialist, with above-average Medicare volume (top 12% in NJ), with low-engagement industry engagement in the top 19% of NJ peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Patel experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Patel performed 1,184 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $4,441 from 56 companies across 279 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other opticians in Toms River?
Dr. Patel's average Medicare payment per service is $119. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →